ESC Professional Premium Access

Acoramidis produces near-complete TTR stabilization in blood samples from patients with variant transthyretin amyloidosis that is greater than that achieved with tafamidis

Congress Presentation

About the speaker

Mr Alan Xian Ji

BridgeBio, San Francisco (United States of America)
0 follower

5 more presentations in this session

Evaluation of disease progression in patients with ATTR amyloidosis with cardiomyopathy following treatment with patisiran: post-hoc analysis of the APOLLO-B study

Speaker: Professor T. Damy (Creteil, FR)

Thumbnail

The use of 99mTc-PYP SPECT/CT in monitoring therapeutic changes of eplontersen in patients with hereditary transthyretin cardiomyopathy

Speaker: Doctor A. Yu (Taipei, TW)

Thumbnail

The role of infliximab in treating refractory cardiac sarcoidosis

Speaker: Doctor R. Ahmed (London, GB)

Thumbnail

Survival analysis of tafamidis use in patients with ATTR cardiac amyloidosis

Speaker: Doctor N. Starr (Co. Limerick, IE)

Thumbnail

Non-adherence to prescribed medications in ambulatory patients with heart failure assessed using liquid chromatography tandem mass spectrometry

Speaker: Doctor S. Sze (Leicester, GB)

Thumbnail

Access the full session

Heart failure red flags and their management

Speakers: Mr A. Ji, Professor T. Damy, Doctor A. Yu, Doctor R. Ahmed, Doctor N. Starr...
Thumbnail

About the event

Image

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

ESC 365 is supported by